Clinical Trial

Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this pilot study is to assess the feasibility and impact of using sodium citrate nasal spray as an adjunct to olfactory retraining in participants with long-term post-COVID-19 olfactory dysfunction. The main questions it aims to answer are: * Is sodium citrate nasal spray in addition to smell retraining feasible for participants to use in terms of participant need/desire, adherence, and adverse events? * Does sodium citrate nasal spray in addition to smell retraining further improve smell as compared to normal saline spray and smell retraining? Participants will: * Provide consent for enrollment. * Undergo smell testing via Sniffin' Sticks. * Use a nasal spray (either sodium citrate or normal saline) followed by olfactory retraining twice a day for 12 weeks. * Return for follow-up Sniffin' Sticks testing. Researchers will compare the sodium citrate group and the normal saline group to determine differences in smell improvement.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-10; most recent amendment 2025-02-17.
Status change: Recruiting → Active, Not Recruiting 2025-02-17
Trial Details
NCT Number NCT06204432
Lead Sponsor University of North Carolina, Chapel Hill
Conditions Long Haul COVID-19, Post-Acute COVID-19 Syndrome, Anosmia, Olfaction Disorders
Enrollment 60 participants
Start Date 2023-12-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-20